BiOptic Inc. is a biotechnology instrumentation company that develops innovative scientific products for research and clinical applications. The company was founded in 2004, with a vision of establishing high-quality, value-added and customer-driven OEM/ODM solutions by developing and manufacturing products utilizing Capillary Gel Electrophoresis (CGE) Technology for biotechnology laboratories all over the world. In 2009 BiOptic started to research and development of an innovative Capillary Gel Electrophoresis instrument utilizing disposable pen-shaped gel-cartridges. The first patented CGE-based Fragment Analyzer Qsep100TM was launched in 2011 at the Lab Automation Conference in Palm Springs, CA. For the past 7 years, BiOptic has expanded its portfolio of products by developing and introducing several CGE instruments: the Qsep1TM, the Gly-QTM, the Qsep400TM, and most recently, the mini-PCR machine, QampminiTM, that incorporates newly launched innovative Direct-PCR reagent kits.